newsfilter
← Latest News
GlobeNewswire·

Selecta Biosciences Announces $38.7 Million Underwritten Offering

WATERTOWN, Mass., April 06, 2022 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ:SELB) ("Selecta" or the "Company"), a biotechnology company focused on developing tolerogenic therapies to mitigate unwanted immune responses, today announced that i